[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fZdywN4hm3f6F5fjVA5BunuC6X-h2-B8EsPAGeVCOBfc":8,"$fk0tTBsfKoNzFbWmOIBpwje9ew4lCjaw8pegraBnG8ow":61,"$fsrpkgE8-m5Kk0jZejJFUXMOlkIVTDBXykNbhozIuR_M":62,"$f-JKTkv1BwIwYwnBMRIoEqQIJtqQs0UgjKKjkhUrHppg":66},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":60},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"roleType":17,"adept":18,"hospital":19,"department":20,"postsTitle":21,"materialTotal":17,"videoTotal":22,"isConcern":7,"title":23,"coverVertical":24,"coverAcross":25,"directionMarker":26,"description":27,"vid":28,"time":29,"mediaType":30,"views":31,"likes":17,"isThumbsUp":7,"isCollection":7,"collections":17,"createTime":32,"seoTitle":33,"seoKeywords":34,"seoDescription":35,"shelvesTime":36,"menus":37,"menuId":39,"type":26,"quality":57,"commentCount":17,"isComment":30,"deviceType":58,"url":59},7000,863398,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//W6OyePPo6ps051zACW5hlRIUH6DBCgnt.png","刘芬",0,"各种肿瘤的诊治","宁乡市人民医院","肿瘤科","主治医师",13,"肺腺癌IVB期患者必看：免疫+化疗联合方案5大生存突破！","https://cdn.yishi-tong.com/console/3/vDeUqMTD6oDWqu28EQfYtgC6v2oSOGkj.png","https://cdn.yishi-tong.com/console/3/JiIrRSkKaxdrFh7eJ-FwO4DTD02g55_j.png",2,"\n\n大家好，我是宁乡市人民医院肿瘤科的刘芬医生。今天我们来聊一聊肺腺癌IVB期患者的治疗方案，特别是免疫联合化疗的优势。\n\n以王初明患者为例，他是一位62岁的男性，来自湖南省长沙市，近期被诊断为IVB期肺腺癌，伴有多脏器病变，包括胸膜和骨转移。患者的临床症状表现为间断性胸闷、咳嗽、咳痰以及精神状态欠佳，生活质量受到严重影响。\n\n在治疗过程中，我们为王初明患者制定了免疫联合化疗方案。该方案的核心在于结合化疗药物与免疫治疗，以期提高疗效。以下是这一方案的五大生存突破：\n\n1. **增强抗肿瘤免疫反应**：免疫治疗通过激活患者自身的免疫系统，帮助识别和攻击癌细胞。与传统化疗相比，免疫治疗能够提供更持久的抗肿瘤效果。\n\n2. **减轻化疗副作用**：化疗药物如顺铂和培美曲塞虽然有效，但也会带来一定的副作用。免疫治疗的加入可以帮助减轻这些副作用，提高患者的耐受性。\n\n3. **个体化治疗方案**：通过基因检测，我们可以为患者量身定制最适合的治疗方案。王初明患者的免疫组化结果为肺腺癌，基因检测结果也为后续治疗提供了重要依据。\n\n4. **改善生活质量**：联合治疗不仅关注肿瘤的控制，还重视患者的生活质量。通过对症治疗和生活习惯的调整（如戒酒），我们希望能帮助患者更好地应对疾病。\n\n5. **定期监测与调整**：在治疗过程中，我们会定期复查患者的血常规和肿瘤标志物，以便及时调整治疗方案，确保最佳疗效。\n\n王初明患者的治疗方案是一个复杂的过程，涉及多种药物和治疗手段。我们在治疗时不仅要关注肿瘤的控制，还要重视患者的整体健康状况和生活质量。希望通过免疫联合化疗，能够为IVB期肺腺癌患者带来新的生存希望。\n\n在此，我也提醒大家，药物治疗并非食品，使用时需遵循医嘱，注意药物的适应症和特殊警告。希望每位患者都能在医生的指导下，找到最适合自己的治疗方案。","v0247cg10004d15540aljhtc7amtt480",190,1,551,"2025-06-03 14:04:38","肺腺癌IVB期免疫+化疗联合方案：5大生存突破与治疗新希望  \n","肺腺癌IVB期,免疫治疗联合化疗,晚期肺癌生存率,PD-1抑制剂,靶向治疗,肿瘤免疫疗法,肺癌治疗方案,生存期延长  \n","针对肺腺癌IVB期患者，免疫联合化疗方案带来5大生存突破！本文详解PD-1抑制剂与化疗协同作用、临床疗效数据及患者生存率提升关键，为晚期肺癌患者提供最新治疗策略和希望。","2025-06-17 11:22:00",[38],{"menuId":39,"menuName":40,"parentId":17,"orderNum":41,"path":42,"component":43,"isFrame":44,"isCache":45,"menuType":46,"visible":30,"status":17,"createDept":6,"remark":47,"createTime":48,"children":49,"columnImage":50,"columnLogo":51,"uncheckedLogo":6,"checkedLogo":6,"isHot":17,"isHome":17,"forceLogin":17,"color":6,"seoTitle":52,"seoKeywords":53,"seoDescription":54,"contentNum":6,"promotionalPoster":55,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":56,"routerPath":42,"componentInfo":43},"1986622624134549505","科普视频",3,"video","/video.html","1","0","T","","2025-11-07 10:31:58",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:40/0d7fcb56-3dc4-4dcb-99ca-a5d5c438378e.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:43/958efac7-dd02-4681-b8fd-0dd84b1bbf42.png","健康科普视频大全,了解你的健康生活","健康科普视频, 戒烟视频, 饮食健康视频, 胸痛科普, 用药知识, 职业健康视频, 贫血科普, 眼健康视频","精选健康科普视频,涵盖戒烟、胸痛、饮食、用药与职业健康等多个主题,让你轻松获取科学健康知识,提升生活质量。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:09:45/fa8fe113-deaa-4454-8105-d629769963dd.png","Video","癌症肿瘤,重大疾病",4,"https://vod.haohuanjiao.com/huanjiao/specialistVideo/863398/8936c105-af55-422b-9739-f00e49b3620f.tmp?a=0&auth_key=1789015294-36fa8e727dca4294b7bb1355724b7d14-0-abaedf7212fdae8db42bf6e75d6219d5&br=829&bt=829&cd=0%7C0%7C0&ch=0&cr=0&cs=0&dr=0&ds=3&eid=v0247cg10004d15540aljhtc7amtt480&er=0&l=20260811023818C5A390F96041B2FC702F&lr=&mime_type=video_mp4&net=0&pl=0&qs=13&rc=Mzd3ZGZrbzM4NDczNGY3M0ApO3dwOndtZDc4ZzMzajo1eWc1cWo0cWdeMTJhLS1kNC9zcy0xcV5gZWktMi4xLS5gMS06Yw%3D%3D&vl=&vr=",true,{"code":9,"msg":59,"message":6,"data":6,"success":60},{"code":9,"msg":10,"message":6,"data":63,"success":60},{"pageNo":30,"pageSize":64,"result":65,"totalSize":17},10,[],{"code":9,"msg":10,"message":6,"data":67,"success":60},{"authors":68,"appraiseDimensionScoresVos":69},[],[]]